500 Global and Ashdod Port Company Unveil Batch 2 of the Ashdod Port Accelerator by 500
6.9.2023 12:00:00 EEST | Business Wire | Press release
Ashdod Port Company, the national port of Israel, and 500 Global, one of the world’s most active multi-stage venture capital firms, today unveil the graduating Israeli startups in Batch 2 of the Ashdod Port Accelerator by 500. These startups attended a rigorous 15-week program – with additional support from a team of Deloitte Israel experts – which gave them the opportunity to work with mentors on topics ranging from growth experiments and customer discovery interviews to testing product-market fit and fundraising. The program also includes participation in an accelerated proof-of-concept process, with the potential for investment by Ashdod Port Company.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230906566212/en/
Batch 2 follows a successful Batch 1 cohort that included startups deploying new technologies at the port and some receiving additional investments from the Ashdod Port Company. Batch 2 of the program will culminate with Demo Day on September 13, 2023, in Tel Aviv. It will be held in person for a curated audience of industry leaders, ecosystem players, and 500 Global network partners. Attendees will hear presentations from a diverse group of startups that are providing solutions to needs in seaport operations, and are building the next generation of companies in sectors such as Industry 4.0, Logistics, Cyber, and Security.
"The investment and support for startups are part of our long-term strategy and future growth engine, which will provide a competitive advantage to ports adapted to the future, both in Israel and around the world,” said Shaul Schneider, Chairman of the Board of Directors of Ashdod Port. “This is one of the few accelerator programs operating in ports in the world. I’m proud of the collaboration with 500 Global, which has proven itself in recent years."
"We are delighted to host our Demo Day here in Israel on September 13 and thank the 500 Global team and the port workers who accompany them,” said Eli Bar Yosef, Acting CEO of Ashdod Port. “By supporting innovation, we are turning Ashdod Port into a smart port, with the aim of spreading the word overseas as well."
“This program is a truly unique initiative, thanks to our partner’s vision and belief that technology can play a central role in modernizing the maritime industry,” said Ee Ling Lim, Executive Director of Market Launch at 500 Global. “Ashdod may be a model for other ports and we believe that it is gaining momentum as a hub for Maritime and Logistics startup founders with exciting potential. Our second batch of startups has gained a solid foundation of corporate partnerships by working with Ashdod Port, and we believe they’re set up to grow in Israel and beyond.”
"500 Global's fruitful partnership with Ashdod Port is a game-changer, positioning the port as a true leader in maritime technology locally and globally," states Tal Chen, Partner at Deloitte Advisory. "This collaborative accelerator is the real deal – it's driving the growth of the Israeli tech scene and helping Ashdod Port shine in maritime technology. After seeing the success of Batch 1 startups, we're excited about Batch 2 Demo Day and confident it'll dish out great results for the Israeli maritime industry."
Tal Chen and Deloitte bring their unique knowledge, skills and experience to the POC processes at Port Ashdod, including the accelerator. This contributes great value to the different processes from spotting promising startups to guiding them through the POC process.
This exclusive event will also feature a panel of industry experts who will share insights on the role of startups in shaping supply chain innovation, as well as trends in the maritime and logistics sector in Israel and around the world. The panel will include representatives from major logistics companies, a startup founder, 500 Global and Ashdod Port Company.
Batch 2 startups are:
- BenderTech is providing a Biometric electronic certificate ID Mobile Application, without Biometric Database, for fast entrance to multi-participant complexes, allows secure and efficient entrance.
- Briefery captures workflow events to ensure process fidelity, tracking, tracing, and analyzing your data for increased efficiency.
- Cynergy is providing a complete framework for an automated remediation ecosystem with the marketplace, SDK, and execution environment.
- Flyz Robotics is a novel autonomous Platform for Deploying Sensors, Devices and Packages on Vertical Walls and other Hard to Reach Spaces.
- Kiami is a knowledge-based technical support SaaS platform for industrial companies, enabling fast troubleshooting of machinery and product failures, and effective cross-team and cross-site knowledge collaboration sites.
- Liquid360 is a patented software that contextualizes real-time security videos and sensor data empowering security teams to act faster and more effectively.
- Magellanic is a Zero-Trust SaaS cybersecurity platform for access control of non-human identities, creating a "Unified Zero Trust Surface" for Machines, Users, APIs and Third Parties.
- Pickommerce is an autonomous pick & pack robotic station with innovative grasping technology, designed to revolutionize the e-commerce logistics landscape.
- ProxyFence is a SaaS platform for continuous API behavioral analysis and documentation.
- SeeAll is a SaaS solution that enables manufacturers to visually track their materials throughout the entire process to ensure process integrity.
- Treedis is a no-code platform that transforms industrial teams into connected workers to increase their efficiency and reduce their downtimes.
- VIDIA has developed a platform based on video analytics for quality control, safety and predictive maintenance applicable for manufacturing, energy and marine industries with working customers.
To register to attend Demo Day, please visit the event page: Supply Chain Innovation - Ashdod Port Accelerator by 500 Global Demo Day .
Ashdod Port
Ashdod Port, The Port of Israel, is the leading seaport of the State of Israel with a strategically advantageous location. Experiencing growing demand, Ashdod Port has incorporated technological advancements into its operations and has inspired other ports around the world. Ashdod Port has collaborated with other institutions and ports to establish innovation embassies that promote growth within the industry. It frequently invests in new equipment and infrastructure for private and public benefit and supports promising early-stage entrepreneurs to bolster the maritime innovation ecosystem in Israel and globally.
500 Global
500 Global is a multi-stage venture capital firm with $2.4B in assets under management as of 30 June 2023 that invests in founders building fast-growing technology companies. We focus on markets where technology, innovation, and capital can unlock long-term value and drive economic growth. We work closely with key stakeholders and advise governments on how best to support entrepreneurial ecosystems so startups can thrive. 500 Global has backed over 5,000 founders representing more than 2,800 companies operating in 80+ countries. We have invested in 35+ companies valued at over $1 billion and 160+ companies valued at over $100 million (including private, public, and exited companies). Our 190+ team members are located in over 25 countries and bring experience as entrepreneurs, investors, and operators from some of the world’s leading technology companies.
DEMO DAY IS AN INVITATION-ONLY EVENT AND THE INTENDED AUDIENCE FOR THIS EVENT IS LIMITED TO "ACCREDITED INVESTORS" AS DEFINED IN REGULATION D UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MEMBERS OF THE PRESS. ALL CONTENT PROVIDED IN THE EVENT IS PROVIDED FOR GENERAL INFORMATIONAL OR EDUCATIONAL PURPOSES ONLY AND SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE BY 500 GLOBAL OR ANY OF ITS AFFILIATES OR AS AN OFFER TO SELL OR SOLICITATION OF INTEREST TO PURCHASE ANY SECURITIES. NO CONTENT OR INFORMATION CONTAINED IN THE EVENT IS OR IS INTENDED AS AN OFFER TO PROVIDE ANY INVESTMENT ADVISORY SERVICE OR FINANCIAL ADVICE BY 500 GLOBAL. UNDER NO CIRCUMSTANCES SHOULD ANY CONTENT HEREIN OR IN THE EVENT BE CONSTRUED AS FUND MARKETING MATERIALS BY PROSPECTIVE INVESTORS CONSIDERING AN INVESTMENT INTO ANY 500 GLOBAL INVESTMENT FUND. INCLUSION AS A PRESENTING COMPANY IN DEMO DAY DOES NOT NECESSARILY CONFIRM INVESTMENT BY A 500 GLOBAL FUND IN SUCH COMPANY. 500 GLOBAL HAS NOT TAKEN ANY ACTIONS TO QUALIFY THE DISTRIBUTION OF THE EVENT UNDER THE SECURITIES LAWS OF ANY JURISDICTION WHERE ACTION FOR THAT PURPOSE IS REQUIRED. PERSONS OUTSIDE OF THE UNITED STATES WHO VIEW THE EVENT MUST OBSERVE ANY APPLICABLE LAWS AND RESTRICTIONS RELATING TO VIEWING THIS EVENT AND ANY RELATED ACTIVITIES OUTSIDE OF THE UNITED STATES.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230906566212/en/
Contact information
JT Eger
Communications at 500 Global
press@500.co
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
